(Q30616078)

15 October 2017

1 reference

Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data (English)

1 reference

15 October 2017

1 reference

Catherine Woodman

28

0 references

Carolyn L Turvey

object named as

Carolyn L Turvey

27

0 references

Suzanne Craft

25

object named as

Suzanne Craft

1 reference

15 October 2017

23

Neil W Kowall

1 reference

15 October 2017

Maurice W Dysken

1

1 reference

15 October 2017

Peter D Guarino

2

1 reference

15 October 2017

Julia E Vertrees

3

1 reference

15 October 2017

Sanjay Asthana

4

1 reference

15 October 2017

Mary Sano

5

1 reference

15 October 2017

Maria Llorente

6

1 reference

15 October 2017

Muralidhar Pallaki

7

1 reference

15 October 2017

Susan Love

8

1 reference

15 October 2017

Gerard D Schellenberg

9

1 reference

15 October 2017

J Riley McCarten

10

1 reference

15 October 2017

Julie Malphurs

11

1 reference

15 October 2017

Susana Prieto

12

1 reference

15 October 2017

Peijun Chen

13

1 reference

15 October 2017

David J Loreck

14

1 reference

15 October 2017

Sara Carney

15

1 reference

15 October 2017

George Trapp

16

1 reference

15 October 2017

Rajbir S Bakshi

17

1 reference

15 October 2017

Jacobo E Mintzer

18

1 reference

15 October 2017

Judith L Heidebrink

19

1 reference

15 October 2017

Ana Vidal-Cardona

20

1 reference

15 October 2017

Lillian M Arroyo

21

1 reference

15 October 2017

Angel R Cruz

22

1 reference

15 October 2017

Mohit P Chopra

24

1 reference

15 October 2017

Stephen Thielke

26

1 reference

15 October 2017

Kimberly A Monnell

29

1 reference

15 October 2017

Kimberly Gordon

30

1 reference

15 October 2017

Julie Tomaska

31

1 reference

15 October 2017

Govind Vatassery

32

1 reference

15 October 2017

11 April 2013

1 reference

15 October 2017

Alzheimer's and Dementia

1 reference

15 October 2017

10

1 reference

15 October 2017

1

1 reference

15 October 2017

36-44

1 reference

Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Cholinesterase inhibitors for Alzheimer's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Vitamin E and donepezil for the treatment of mild cognitive impairment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The role of oxidative stress in Alzheimer disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The glutamatergic system and neurodegeneration in dementia: preventive strategies in Alzheimer's disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Excitatory amino acids as a final common pathway for neurologic disorders.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

A new rating scale for Alzheimer's disease.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Significance testing in the comparison of survival curves from clinical trials of cancer treatment.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Changes in vitamin E prescribing for Alzheimer patients

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Memantine in moderate-to-severe Alzheimer's disease

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

Assessing patient dependence in Alzheimer's disease.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4128187

The impact of self-reported cumulative comorbidity on stroke recovery

25 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23583234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Co-morbidity adjustment for functional outcomes in community-dwelling older adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23583234

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JALZ.2013.01.014

1 reference

15 October 2017

1 reference

15 October 2017

PubMed publication ID

23583234

1 reference